Table 1.
Patient characteristics
| Patients, N | 50 |
| Median age, y (range) | 64 (18–81) |
| Gender | 13 F / 37 M |
| WHO classification | |
| Refractory anemia | 7 |
| Refractory anemia with ringed sideroblasts | 4 |
| Refractory cytopenia with multilineage dysplasia | 6 |
| Refractory cytopenia with multilineage dysplasia and ringed sideroblasts |
2 |
| Refractory anemia with excess blasts 1 | 6 |
| Refractory anemia with excess blasts 2 | 12 |
| MDS-AML | 6 |
| Chronic myelomonocytic leukemia | 7 |
| IPSS score | |
| Low | 6 |
| Intermediate-1 | 17 |
| Intermediate-2 | 13 |
| High | 13 |
| Not available | 1 |
| Previous Treatment | |
| Growth Factor | 23 |
| Azacitidine | 10 |
| Anthi-thymocyte globulin | 3 |
| Thalidomide / lenalidomide | 8 |
| Cytotoxic Chemotherapy | 6 |